← Browse by Condition
Medical Condition
pancreatic neoplasm
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2
NCT04493632
Recruiting
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
Enrollment
500 pts
Location
Spain, United Kingdo...
Sponsor
OncoSil Medical Limited
NCT06526442
Recruiting
MRE for Diagnosis of Pancreatic Masses
Enrollment
200 pts
Location
China
Sponsor
Yu Shi
NCT05687123 Phase 1
Recruiting
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Enrollment
24 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
NCT07045571
Recruiting
MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
Enrollment
1,000 pts
Location
China
Sponsor
Yingbin Liu, MD, PhD, FACS
NCT07396662
Recruiting
Endocrine-exocrine Functions and Prognosis After Pancreatectomy
Enrollment
3,500 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT05083247 Phase 2
Recruiting
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Enrollment
256 pts
Location
Belgium
Sponsor
Erasme University Hospital